These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9813 related articles for article (PubMed ID: 1873775)

  • 1. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
    Buzaid AC; Murren JR; Durivage HJ
    Cancer; 1991 Sep; 68(6):1238-41. PubMed ID: 1873775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
    Steffens TA; Bajorin DF; Chapman PB; Lovett DR; Cody-Johnson BV; Templeton MA; Heelan RT; Wong GY; Portlock CS; Oettgen HF
    Cancer; 1991 Sep; 68(6):1230-7. PubMed ID: 1873774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
    Rusthoven JJ; Quirt IC; Iscoe NA; McCulloch PB; James KW; Lohmann RC; Jensen J; Burdette-Radoux S; Bodurtha AJ; Silver HK; Verma S; Armitage GR; Zee B; Bennett K
    J Clin Oncol; 1996 Jul; 14(7):2083-90. PubMed ID: 8683240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.
    Richard MA; Grob JJ; Zarrour H; Bassères N; Bizzari JP; Gérard B; Bonerandi JJ
    Melanoma Res; 1998 Apr; 8(2):170-4. PubMed ID: 9610872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.
    Margolin KA; Liu PY; Flaherty LE; Sosman JA; Walker MJ; Smith JW; Fletcher WS; Weiss GR; Unger JM; Sondak VK
    J Clin Oncol; 1998 Feb; 16(2):664-9. PubMed ID: 9469356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.
    McClay EF; Mastrangelo MJ; Sprandio JD; Bellet RE; Berd D
    Cancer; 1989 Apr; 63(7):1292-5. PubMed ID: 2920358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
    McClay EF; Mastrangelo MJ; Bellet RE; Berd D
    Cancer Treat Rep; 1987 May; 71(5):465-9. PubMed ID: 3567970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program.
    Stark JJ; Dillman RO; Schulof R; Wiemann MC; Barth NM; Honeycutt PJ; Soori G
    Cancer; 1998 May; 82(9):1677-81. PubMed ID: 9576288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).
    Flaherty LE; Liu PY; Mitchell MS; Fletcher WS; Walker MJ; Goodwin JW; Stephens RL; Sondak VK
    Am J Clin Oncol; 1996 Apr; 19(2):108-13. PubMed ID: 8610631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
    Murren JR; DeRosa W; Durivage HJ; Davis C; Makuch R; Portlock CS
    Cancer; 1991 Mar; 67(6):1514-7. PubMed ID: 2001539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.
    Schultz MZ; Buzaid AC; Poo WJ
    Melanoma Res; 1997 Apr; 7(2):147-51. PubMed ID: 9167181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study.
    Stein ME; Bernstein Z; Tsalic M; Drumea K; Steiner M; Sklar Z; Haim N
    Am J Clin Oncol; 2002 Oct; 25(5):460-3. PubMed ID: 12393984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.
    Margolin KA; Liu PY; Unger JM; Fletcher WS; Flaherty LE; Urba WJ; Hersh EM; Hutchins LE; Sosman JA; Smith JW; Weiss GR; Sondak VK
    J Cancer Res Clin Oncol; 1999; 125(5):292-6. PubMed ID: 10359134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
    Dillman RO; Soori G; Wiemann MC; Schulof R; Dobbs TW; Ruben RH; DePriest CB; Church C
    Cancer Biother Radiopharm; 2000 Oct; 15(5):487-94. PubMed ID: 11155820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.
    Stein ME; Bernstein Z; Drumea K; Zalik M; Shklar Z; Steiner M; Haim N
    Am J Clin Oncol; 1999 Feb; 22(1):62-4. PubMed ID: 10025383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
    Chapman PB; Einhorn LH; Meyers ML; Saxman S; Destro AN; Panageas KS; Begg CB; Agarwala SS; Schuchter LM; Ernstoff MS; Houghton AN; Kirkwood JM
    J Clin Oncol; 1999 Sep; 17(9):2745-51. PubMed ID: 10561349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.
    Chiarion Sileni V; Nortilli R; Aversa SM; Paccagnella A; Medici M; Corti L; Favaretto AG; Cetto GL; Monfardini S
    Melanoma Res; 2001 Apr; 11(2):189-96. PubMed ID: 11333130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
    Nathanson L; Meelu MA; Losada R
    Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 491.